73 related articles for article (PubMed ID: 16009953)
1. Thymidylate synthase in nodal metastases: prognostic for chemosensitivity but not for adjuvant therapy?
Ahlgren JD
J Clin Oncol; 2005 Aug; 23(24):5452-4. PubMed ID: 16009953
[No Abstract] [Full Text] [Related]
2. Detection of thymidylate synthase expression in lymph node metastases of colorectal cancer can improve the prognostic information.
Ohrling K; Edler D; Hallström M; Ragnhammar P; Blomgren H
J Clin Oncol; 2005 Aug; 23(24):5628-34. PubMed ID: 16009948
[TBL] [Abstract][Full Text] [Related]
3. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ
Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
Yamada H; Iinuma H; Watanabe T
Oncol Rep; 2008 Mar; 19(3):729-35. PubMed ID: 18288408
[TBL] [Abstract][Full Text] [Related]
6. Prognostic markers of local relapse in rectal cancer: are we any further forward?
Johnston PG
J Clin Oncol; 2006 Sep; 24(25):4049-50. PubMed ID: 16943520
[No Abstract] [Full Text] [Related]
7. Prognostic significance of numeric aberrations of genes for thymidylate synthase, thymidine phosphorylase and dihydrofolate reductase in colorectal cancer.
Jensen SA; Vainer B; Witton CJ; Jørgensen JT; Sørensen JB
Acta Oncol; 2008; 47(6):1054-61. PubMed ID: 18607850
[TBL] [Abstract][Full Text] [Related]
8. Tumor thymidylate synthase 1494del6 genotype as a prognostic factor in colorectal cancer patients receiving fluorouracil-based adjuvant treatment.
Dotor E; Cuatrecases M; Martínez-Iniesta M; Navarro M; Vilardell F; Guinó E; Pareja L; Figueras A; Molleví DG; Serrano T; de Oca J; Peinado MA; Moreno V; Germà JR; Capellá G; Villanueva A
J Clin Oncol; 2006 Apr; 24(10):1603-11. PubMed ID: 16575011
[TBL] [Abstract][Full Text] [Related]
9. Thymidylate synthase levels: prognostic, predictive, or both?
Allegra C
J Clin Oncol; 2002 Apr; 20(7):1711-3. PubMed ID: 11919223
[No Abstract] [Full Text] [Related]
10. Comparative analysis of thymidylate synthase at the protein, mRNA, and DNA levels as prognostic markers in colorectal adenocarcinoma.
Ren DN; Kim IY; Koh SB; Chang SJ; Eom M; Yi SY; Seong SH; Kim MD; Bronner MP; Cho MY
J Surg Oncol; 2009 Dec; 100(7):546-52. PubMed ID: 19722231
[TBL] [Abstract][Full Text] [Related]
11. Studying the predictive/prognostic role of thymidylate synthase genotypes in patients with colorectal cancer: Is one polymorphism enough?
Graziano F; Kawakami K
J Clin Oncol; 2005 Oct; 23(28):7230-1; author reply 7231. PubMed ID: 16192610
[No Abstract] [Full Text] [Related]
12. Thymidylate synthase expression in colorectal cancer: the never-ending story.
Vincenzi B; Santini D; Tonini G
J Clin Oncol; 2005 Mar; 23(9):2108; author reply 2108-9. PubMed ID: 15774806
[No Abstract] [Full Text] [Related]
13. High thymidylate synthase expression is typical for sporadic MSI-H colorectal carcinoma.
Okoń K; Klimkowska A; Wójcik P; Osuch C; Papla B; Stachura J
Pol J Pathol; 2006; 57(1):29-33. PubMed ID: 16739880
[TBL] [Abstract][Full Text] [Related]
14. Prognostic predictors in breast cancer patients with postoperative 5-fluorouracil-based chemotherapy.
Hakamada Y; Tsuchida A; Arima M; Kubouchi T; Tokita H; Ota D; Kaise H; Aoki T; Kusama M; Aoki T
Int J Mol Med; 2005 Aug; 16(2):309-14. PubMed ID: 16012767
[TBL] [Abstract][Full Text] [Related]
15. Expression level of thymidylate synthase mRNA reflects 5-fluorouracil sensitivity with low dose and long duration in primary colorectal cancer.
Okumura K; Mekata E; Shiomi H; Naitoh H; Abe H; Endo Y; Kurumi Y; Tani T
Cancer Chemother Pharmacol; 2008 Apr; 61(4):587-94. PubMed ID: 17520254
[TBL] [Abstract][Full Text] [Related]
16. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacogenetic studies on the prediction of efficacy and toxicity of fluoropyrimidine-based adjuvant therapy in colorectal cancer].
Kralovánszky J; Adleff V; Hitre E; Pap E; Réti A; Komlósi V; Budai B
Magy Onkol; 2007; 51(2):113-25. PubMed ID: 17660867
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between clinical pathologic factors and enzymatic activity of orotate Phosphoribosyl transferase (OPRT), Dihydropyrimidine dehydrogenase (DPD) and Thymidylate synthase (TS) in colorectal cancer].
Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Kanazawa Y; Shirakawa T; Ohkawa K; Koizumi M; Ohaki Y; Yamashita K; Tajiri T
Gan To Kagaku Ryoho; 2006 Jun; 33(6):789-93. PubMed ID: 16770098
[TBL] [Abstract][Full Text] [Related]
20. Expression of thymidylate synthase in liver and lung metastases of colorectal cancer and their matched primary tumours.
Ohrling K; Edler D; Hallström M; Ragnhammar P
Anticancer Res; 2008; 28(3B):1741-7. PubMed ID: 18630453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
